Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate Cancer
Launched by UNIVERSITY OF ALBERTA · Oct 2, 2023
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
The CONTROL 4 LIFE study is looking at how men recover after surgery for prostate cancer, specifically focusing on issues like bladder control, sexual health, and overall well-being. Researchers want to understand how long it takes for men to regain these aspects of their health after surgery and will provide participants with helpful resources, including information on exercises that can support recovery. The study aims to improve our understanding of recovery timelines and the overall quality of life for these patients.
To participate in this study, you need to be a man aged 18 or older who has been diagnosed with prostate cancer and is scheduled for surgery. You should also be able to do at least some physical activity and understand English. Participants can expect to receive guidance on their health before and after surgery, and some may have the option to join a 12-week exercise program to help with recovery. This study is currently recruiting, so if you meet the criteria, it could be a great opportunity to help improve care for men undergoing prostate cancer surgery.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • have a diagnosis of prostate cancer (stage I to IV);
- • be scheduled for a prostatectomy surgery (any surgical approach);
- • have no restriction to participate in at least mild levels of physical activity, as confirmed by the Physical Activity Readiness Questionnaire (PAR-Q+);
- • speak and understand English.
- • adult: 18 years of age or older
- • optional exercise component: willing and able to commit to the 12-week intervention
- Exclusion Criteria:
- • have any medical conditions that may interfere with continence (i.e. neurological diseases);
- • have any contraindications to exercise testing or training;
- • have recent (\>6 months) modifications to any medication aiming to reduce urinary incontinence (i.e. Myrbetric);
- • do not have regular access to the internet and a smart device or a computer at home/ at their community center;
- • are already receiving a pelvic floor exercise program through a pelvic floor physical therapist from their community.
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Edmonton, Alberta, Canada
Patients applied
Trial Officials
Nathan Hoy, MD
Principal Investigator
University of Alberta
Howard Evans, MD
Principal Investigator
University of Alberta
Margaret McNeely
Principal Investigator
University of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported